IP Library › Granted Patent US 12,630,719
Granted Patent B2
US 12,630,719 · App. 17/777,506 · Granted May 19, 2026

Fluorescent acridinium salts, synthesis thereof and use for detection of cardiolipin

Inventors: Pavels Arsenjans (Riga, LV); Pavels Dimitrijevs (Daugavpils, LV)
Assignee: Latvian Institute of Organic Synthesis
C09B69/008G01N33/582G01N33/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,630,719
App. No.
17/777,506
Granted
May 19, 2026
Kind
B2
Abstract

The present invention relates to a novel substituted acridinium salts as fluorescent dyes, as well as methods of their manufacturing and use of the disclosed compounds for the detection of cardiolipin.

Claims (19)

1 . A compound of Formula I:

wherein

R represents C 1-6 -alkylene-silyl(C 1-3 -alkyl) 3 ; and

X − represents chloride, bromide, or iodide.

2 . The compound of claim 1 , wherein the compound has the structure:

3 . A process for the synthesis of a compound of Formula I:

wherein:

R represents C 1-15 alkyl, C 1-3 deuterated alkyl, or C 1-6 -alkylene-silyl(C 1-3 -alkyl) 3 ; and

X − represents chloride, bromide, or iodide;

comprising reacting a compound 1:

with C 1-12 alkyl halide, C 1-3 deuterated alkyl halide, or C 1-6 -alkylene-silyl(C 1-3 -alkyl) 3 halide in the presence of potassium phosphate.

4 . The compound of claim 1 , wherein R is C 1-3 -alkylene-silyl(C 1-3 -alkyl) 3 .

5 . The compound of claim 4 , wherein R is (CH 2 ) 3 —Si(CH 3 ) 3 .

6 . The compound of claim 5 , wherein X − is iodide.

7 . The process of claim 3 , wherein R is C 1-12 alkyl, deuterated methyl, or C 1-3 -alkylene-silyl(C 1-3 -alkyl) 3 .

8 . The process of claim 7 , wherein R is CH 3 , CD 3 , C 9 H 19 , C 12 H 25 , or (CH 2 ) 3 —Si(CH 3 ) 3 .

9 . The process of claim 8 , wherein X − is iodide.

10 . A method of detecting cardiolipin comprising contacting the compound of claim 1 with cardiolipin.

11 . The method of claim 10 , further comprising detecting a loss in fluorescence intensity.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2026
From: LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
To: NATIONAL INSTITUTE OF RESEARCH AND INNOVATION
Reel/Frame 075708/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2022
From: ARSENJANS, PAVELS; DIMITRIJEVS, PAVELS
To: LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
Reel/Frame 060489/0817 →
Priority Claims (1)
LV P-19-64 · Nov 28, 2019 · national
Continuity (1)
Related Publication 20230013542A1 · Jan 19, 2023
References Cited (18)
US 4193983A · Ullman et al. · 1980 [cited by applicant]
CN 107090190A · 2017 [cited by applicant]
CN 107807238A · 2018 [cited by applicant]
WO WO2013093481A1 · 2013 [cited by applicant]
WO WO2015153813A1 · 2015 [cited by applicant]
WO WO2021105780 · 2021 [cited by applicant]
WO WO2022038424 · 2022 [cited by applicant]
No new references cited by the Examiner. [cited by examiner]
Kaewsuya P et al., “Fluorescent determination of cardiolipin using 10-N-nonyl acridine orange”, Analytical and Bioanalytical Chemistry, Springer, Berlin, DE, vol. 387, No. 8, Feb. 15, 2007, pp. 2775-2782. [cited by applicant]
Kaewuya P et al., “Comparison of N-alkyl acridine orange dyes as fluorescence probes for the determination of cardiolipin”, Analytica Chimica Acta, Elsevier, Amsterdam, NL, vol. 626, No. 2, Sep. 26, 2008, pp. 111-118. [cited by applicant]
International Search Report for PCT/IB3030/058457, mailed on Sep. 12, 2020, 2 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln No. PCT/IB2020/058457, mailed on Dec. 9, 2020, 8 pages. [cited by applicant]
Mather et al., “Polycations induce the release of soluble intermembrane mitochondrial proteins,” Biochem Biophys Acta, Sep. 2000, 1503(3):357-368. [cited by applicant]
Nicolay et al., “The Interaction of Adriamycin with Cardiolipin in Model and Rat Liver Mitochondrial Membranes,” Biochem Biophys Acta, Jun. 1984, 778(2):359-371. [cited by applicant]
Parker et al., “Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers,” Biochem Biophys Acta, Jun. 2001, 1514(2):206-216. [cited by applicant]
Sautrey et al., “Negatively-charged Lipids as Potential Target for New Amphiphilic Aminoglycoside Antibiotics: a biophysical study,” J. Biological Chem., May 2016, M115.665364, 35 pages. [cited by applicant]
Sinibaldi et al., “Insights into Cytochrome c-Cardiolipin Interaction. Role Played by Ionic Strength,” Biochemistry, Apr. 2008, 47(26):6928-6935. [cited by applicant]
Soussi et al., “H-n.m.r. evaluation of the ferricytochrome c-cardiolipin interaction,” Biochem. J., Aug. 1989, 265(1):227-232. [cited by applicant]